This page shows Ambase (ABCP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Balance-sheet erosion is the dominant mechanic, with assets and cash nearly exhausted while liabilities keep accumulating.
From FY2021 to FY2025, total assets fell from$3.1M to$87K . Over the same span, total liabilities rose from$684K to$8.8M , so the company became a much smaller asset base supporting a much larger set of claims.
The move from positive equity of
Some figures from recent filings were inconsistent and were omitted from this summary.
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Ambase's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Ambase carries a low D/E ratio of -1.01, meaning only $-1.01 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 96/100, indicating a strong balance sheet with room for future borrowing.
Key Financial Metrics
Earnings & Revenue
Cash & Balance Sheet
Ambase held $87K in cash against $0 in long-term debt as of fiscal year 2025.
Ambase had 85M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Margins & Returns
Capital Allocation
ABCP Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $324K | N/A | $324K+0.6% | $322K-13.2% | $371K | N/A | $345K-2.0% | $352K |
| Operating Income | -$678K | N/A | -$985K | N/A | N/A | N/A | -$1.5M+24.0% | -$2.0M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $0 | N/A | $0 | $0 | $0 | N/A | $0 | $0 |
| Net Income | -$775K | N/A | -$1.1M | N/A | N/A | N/A | -$1.5M+20.8% | -$1.9M |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ABCP Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $533K+512.6% | $87K-63.6% | $239K+119.3% | $109K-45.5% | $200K-36.3% | $314K-39.0% | $515K+18.7% | $434K |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $533K+512.6% | $87K-63.6% | $239K+119.3% | $109K-45.5% | $200K-36.3% | $314K-39.0% | $515K+18.7% | $434K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $10.0M+13.9% | $8.8M+7.9% | $8.1M+17.7% | $6.9M+16.8% | $5.9M+33.3% | $4.4M+33.4% | $3.3M+94.2% | $1.7M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$9.5M-8.9% | -$8.7M-10.1% | -$7.9M-16.0% | -$6.8M-18.9% | -$5.7M-38.6% | -$4.1M-46.7% | -$2.8M-119.9% | -$1.3M |
| Retained Earnings | -$561.9M-0.1% | -$561.1M-0.1% | -$560.3M-0.2% | -$559.2M-0.2% | -$558.2M-0.3% | -$556.6M-0.2% | -$555.3M-0.3% | -$553.7M |
ABCP Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.5M | N/A | -$470K | N/A | -$614K+12.4% | -$701K | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $1.9M+375.0% | $400K-33.3% | $600K | N/A | $500K0.0% | $500K | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ABCP Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -145.4% | N/A | -456.5% | N/A | N/A | N/A | -297.7%+148.2pp | -445.8% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | -1.06-0.0 | -1.01+0.0 | -1.03-0.0 | -1.02+0.0 | -1.03+0.0 | -1.08+0.1 | -1.18+0.2 | -1.34 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$8.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Frequently Asked Questions
What are Ambase's total assets?
Ambase (ABCP) had $87K in total assets as of fiscal year 2025, including both current and long-term assets.
What is Ambase's debt-to-equity ratio?
Ambase (ABCP) had a debt-to-equity ratio of -1.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
Why is Ambase's debt-to-equity ratio negative or unusual?
Ambase (ABCP) has negative shareholder equity of -$8.7M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
How financially healthy is Ambase?
Ambase (ABCP) scores 16 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.